Erhaltungstherapie mit Olaparib nach platinhaltiger Re-induktion bei platinsensitivem serösem Ovarialkarzinomrezidiv: eine Placebo-kontrollierte Phase II Studie
Year: 2014
Type: article
Study design: Clinical Trial
Source: Geburtshilfe und Frauenheilkunde
Institutions: Kliniken Essen-Mitte, Essen University Hospital, TUM Klinikum, Technical University of Munich, Universitätsmedizin Göttingen, University Hospital Ulm, University Hospital Schleswig-Holstein, Dana-Farber Cancer Institute, Edinburgh Cancer Research, University of Edinburgh, Prince of Wales Hospital, KU Leuven, Mount Vernon Hospital, The Royal Melbourne Hospital, Evangelisches Krankenhaus Düsseldorf, Sheba Medical Center, Tel Aviv Sourasky Medical Center, Indiana University School of Medicine, AstraZeneca (United Kingdom), AstraZeneca (United States), University College London
Language: German
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2333058030